全文获取类型
收费全文 | 792篇 |
免费 | 96篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 19篇 |
妇产科学 | 43篇 |
基础医学 | 111篇 |
口腔科学 | 5篇 |
临床医学 | 96篇 |
内科学 | 122篇 |
皮肤病学 | 8篇 |
神经病学 | 91篇 |
特种医学 | 58篇 |
外科学 | 132篇 |
综合类 | 33篇 |
预防医学 | 86篇 |
眼科学 | 25篇 |
药学 | 23篇 |
肿瘤学 | 38篇 |
出版年
2021年 | 6篇 |
2020年 | 6篇 |
2019年 | 9篇 |
2018年 | 8篇 |
2017年 | 12篇 |
2016年 | 11篇 |
2015年 | 17篇 |
2014年 | 16篇 |
2013年 | 24篇 |
2012年 | 31篇 |
2011年 | 26篇 |
2010年 | 18篇 |
2009年 | 23篇 |
2008年 | 38篇 |
2007年 | 47篇 |
2006年 | 30篇 |
2005年 | 33篇 |
2004年 | 34篇 |
2003年 | 37篇 |
2002年 | 23篇 |
2001年 | 36篇 |
2000年 | 34篇 |
1999年 | 34篇 |
1998年 | 23篇 |
1997年 | 9篇 |
1996年 | 14篇 |
1995年 | 13篇 |
1994年 | 20篇 |
1993年 | 17篇 |
1992年 | 10篇 |
1991年 | 15篇 |
1990年 | 9篇 |
1989年 | 16篇 |
1988年 | 17篇 |
1987年 | 18篇 |
1986年 | 13篇 |
1985年 | 12篇 |
1984年 | 12篇 |
1983年 | 12篇 |
1982年 | 8篇 |
1981年 | 15篇 |
1980年 | 6篇 |
1976年 | 4篇 |
1975年 | 5篇 |
1974年 | 5篇 |
1973年 | 5篇 |
1972年 | 6篇 |
1970年 | 6篇 |
1969年 | 4篇 |
1966年 | 7篇 |
排序方式: 共有895条查询结果,搜索用时 562 毫秒
1.
2.
3.
Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma 总被引:9,自引:3,他引:6
Weisenburger DD; Gordon BG; Vose JM; Bast MA; Chan WC; Greiner TC; Anderson JR; Sanger WG 《Blood》1996,87(9):3860-3868
Primary CD30(Ki-1)-positive anaplastic large-cell lymphoma (ALCL) is considered by some to be a distinct clinicopathologic entity associated with the t(2;5) (p23;q35). However, the specificity of t(2;5) for ALCL has not been carefully studied. Therefore, we performed a detailed analysis of all cases of ALCL with abnormal cytogenetics results in the Nebraska Lymphoma Study Group registry, as well as all other cases of non-Hodgkin's lymphoma with t(2;5) in the registry. We found the t(2;5) in only five of 10 cases of ALCL, four of whom were young patients. However, we also found the t(2;5) in 11 other cases of nonanaplastic lymphoma, including eight children with typical peripheral T-cell lymphomas of various types. The t(2;5) was also found in three older adults with B-cell lymphomas of various types. Thus, the t(2;5) was not specific for CD30+ ALCL. However, t(2;5) may define a clinicopathologic entity in children and young adults characterized by variable morphologies with a T-cell or indeterminate phenotype, CD30-positivity, nodal disease with frequent extranodal involvement, advanced stage, and an excellent response to therapy, including bone marrow transplantation for relapsed disease. The clinical relevance of the t(2;5) in older patients requires further study. 相似文献
4.
Conservative surgery and radiation therapy in black women with early stage breast cancer. Patterns of failure and analysis of outcome. 总被引:3,自引:0,他引:3
Between 1977 and 1986, 75 black and 615 white women with American Joint Committee (AJC) Stages I and II breast cancer were treated with excisional biopsy, axillary dissection, and radiation therapy for breast conservation. Cyclophosphamide, methotrexate, and 5-fluorouracil, with and without prednisone and tamoxifen, was given to 92% of premenopausal, 83% of perimenopausal, and 63% of postmenopausal node-positive women; 20 of 106 (19%) postmenopausal node-positive women received tamoxifen only. The clinical characteristics of the similarly treated patients were compared. The 5-year actuarial local only first failure rate was 5% for black women and 6% for white women (P = 0.53). Regional only failure as the first site of failure was 9% for blacks versus 1% for whites (P = 0.002), with regional recurrence as any component of first failure being 16% for blacks and 4% for whites (P = 0.001). The supraclavicular fossa was identified as the primary site of regional recurrence in black patients with either pathologically positive or negative axillae. Distant metastases as the only site of first failure were significantly greater in the black population with a 20% 5-year actuarial failure rate versus 11% in white patients (P = 0.01). The 5-year actuarial overall survival for the black patients was 82% versus 91% for the white patients (P = 0.01), with no-evidence-of-disease (NED) survival being 64% and 83% (P = 0.0002) and relapse-free survival (RFS) being 61% and 77% (P = 0.01), respectively. Black patients younger than 40 years of age or with pathologically positive axillary nodes had significantly worse NED, RFS, and overall survival compared with similarly staged white patients. Cosmetic results were analyzed at 3 and 5 years after completion of therapy. Although significantly fewer black patients had an excellent-to-good cosmetic result at 3 years compared with white patients, the results were not significantly different at 5 years. These results show that appropriately selected black patients with early stage breast cancer have excellent local control after conservative surgery and radiation therapy and should continue to be offered breast preservation as an alternative to mastectomy. Patterns of failure, however, demonstrated higher regional and distant recurrence rates and lower NED, RFS, and overall survival rates in most subsets of black patients reviewed. 相似文献
5.
6.
7.
Braffman BH; Coleman BG; Ramchandani P; Arger PH; Nodine CF; Dinsmore BJ; Louie A; Betsch SE 《Radiology》1994,190(3):797
8.
9.
10.
Breast cancer in women after augmentation mammoplasty 总被引:1,自引:0,他引:1
M J Silverstein N Handel P Gamagami J R Waisman E D Gierson R J Rosser R Steyskal W Colburn 《Archives of surgery (Chicago, Ill. : 1960)》1988,123(6):681-685
More than 1 million American women have undergone augmentation mammoplasty; 100,000 (10%) will develop or already have developed breast cancer. Between March 1981 and August 1986, 20 patients with previous augmentation mammoplasty were treated for breast carcinoma. All patients had unilateral infiltrating carcinomas and presented with a palpable mass. None of the cancers were occult (discovered mammographically). Thirteen patients (65%) had metastases to axillary lymph nodes. During the same period, 733 nonaugmented patients with breast cancer were treated: 207 (28%) had involved axillary nodes, 194 (26%) had in situ lesions, and 154 cancers (21%) were occult. Augmentation mammoplasty with sillicone-gel-filled implants reduces the ability of mammography, our best diagnostic tool, to visualize breast parenchyma. When compared with our own nonaugmented breast cancer population, augmented patients with breast cancer presented with more advanced disease; they had a higher percentage of invasive lesions and positive axillary nodes, resulting in a worsened prognosis. 相似文献